These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31396348)

  • 21. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification of factors involved in nonreportable results of noninvasive prenatal testing (NIPT) and prediction of success rate of second NIPT.
    Suzumori N; Sekizawa A; Takeda E; Samura O; Sasaki A; Akaishi R; Wada S; Hamanoue H; Hirahara F; Kuriki H; Sawai H; Nakamura H; Yamada T; Miura K; Masuzaki H; Yamashita T; Kamei Y; Namba A; Murotsuki J; Tanemoto T; Fukushima A; Haino K; Tairaku S; Matsubara K; Maeda K; Kaji T; Ogawa M; Osada H; Nishizawa H; Okamoto Y; Kanagawa T; Kakigano A; Endo M; Kitagawa M; Ogawa M; Izumi S; Katagiri Y; Takeshita N; Kasai Y; Naruse K; Neki R; Masuyama H; Hyodo M; Kawano Y; Ohba T; Ichizuka K; Nagamatsu T; Watanabe A; Nishikawa N; Hamajima N; Shirato N; Yotsumoto J; Nishiyama M; Koide K; Hirose T; Sago H
    Prenat Diagn; 2019 Jan; 39(2):100-106. PubMed ID: 30586157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.
    Dharajiya NG; Grosu DS; Farkas DH; McCullough RM; Almasri E; Sun Y; Kim SK; Jensen TJ; Saldivar JS; Topol EJ; van den Boom D; Ehrich M
    Clin Chem; 2018 Feb; 64(2):329-335. PubMed ID: 28982650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Reference Materials for Noninvasive Prenatal Aneuploidy Testing by Massively Parallel Sequencing: A Proof-of-Concept Study.
    Blais J; Giroux S; Caron A; Clément V; Rousseau F
    J Appl Lab Med; 2019 Jul; 4(1):50-60. PubMed ID: 31639707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction.
    Morano D; Rossi S; Lapucci C; Pittalis MC; Farina A
    Mol Diagn Ther; 2018 Oct; 22(5):613-619. PubMed ID: 30056492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid Metabolism Affects Fetal Fraction and Screen Failures in Non-invasive Prenatal Testing.
    Cao J; Qiao L; Jin J; Zhang S; Chen P; Tang H; Yu Z; Shi J; Wang T; Liang Y
    Front Med (Lausanne); 2021; 8():811385. PubMed ID: 35096900
    [No Abstract]   [Full Text] [Related]  

  • 27. Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24h after venipuncture.
    Buysse K; Beulen L; Gomes I; Gilissen C; Keesmaat C; Janssen IM; Derks-Willemen JJ; de Ligt J; Feenstra I; Bekker MN; van Vugt JM; Geurts van Kessel A; Vissers LE; Faas BH
    Clin Biochem; 2013 Dec; 46(18):1783-6. PubMed ID: 23933476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancy.
    Kim S; Jung H; Han SH; Lee S; Kwon J; Kim MG; Chu H; Chen H; Han K; Kwak H; Park S; Joo HJ; Kim BC; Bhak J
    BMC Med Genomics; 2016 Apr; 9(1):22. PubMed ID: 27129388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia.
    Rolnik DL; da Silva Costa F; Lee TJ; Schmid M; McLennan AC
    Ultrasound Obstet Gynecol; 2018 Dec; 52(6):722-727. PubMed ID: 29318732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gestational diabetes mellitus diagnosed at 24 to 28 weeks of gestation in older and obese Women: Is it too late?
    Kim W; Park SK; Kim YL
    PLoS One; 2019; 14(12):e0225955. PubMed ID: 31841546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microarray-based cell-free DNA analysis improves noninvasive prenatal testing.
    Juneau K; Bogard PE; Huang S; Mohseni M; Wang ET; Ryvkin P; Kingsley C; Struble CA; Oliphant A; Zahn JM
    Fetal Diagn Ther; 2014; 36(4):282-6. PubMed ID: 25228026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An adaptive detection method for fetal chromosomal aneuploidy using cell-free DNA from 447 Korean women.
    Kim S; Jung H; Han SH; Lee S; Kwon J; Kim MG; Chu H; Han K; Kwak H; Park S; Joo HJ; An M; Ha J; Lee K; Kim BC; Zheng H; Zhu X; Chen H; Bhak J
    BMC Med Genomics; 2016 Oct; 9(1):61. PubMed ID: 27716407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors relevant to newborn birth weight in pregnancy complicated with abnormal glucose metabolism].
    Yang YD; Zhai GR; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):646-51. PubMed ID: 21092542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using Targeted Sequencing of Paralogous Sequences for Noninvasive Detection of Selected Fetal Aneuploidies.
    Ellison CK; Sun Y; Hogg G; Fox J; Tao H; McCarthy E; Sagoe B; Azab MA; Mazloom AR; Tynan J; Burcham T; Kim SK; van den Boom D; Ehrich M; Jensen TJ
    Clin Chem; 2016 Dec; 62(12):1621-1629. PubMed ID: 27694391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy.
    Suzumori N; Sekizawa A; Ebara T; Samura O; Sasaki A; Akaishi R; Wada S; Hamanoue H; Hirahara F; Izumi H; Sawai H; Nakamura H; Yamada T; Miura K; Masuzaki H; Yamashita T; Okai T; Kamei Y; Namba A; Murotsuki J; Tanemoto T; Fukushima A; Haino K; Tairaku S; Matsubara K; Maeda K; Kaji T; Ogawa M; Osada H; Nishizawa H; Okamoto Y; Kanagawa T; Kakigano A; Kitagawa M; Ogawa M; Izumi S; Katagiri Y; Takeshita N; Kasai Y; Naruse K; Neki R; Masuyama H; Hyodo M; Kawano Y; Ohba T; Ichizuka K; Nagamatsu T; Watanabe A; Shirato N; Yotsumoto J; Nishiyama M; Hirose T; Sago H
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():165-169. PubMed ID: 29605711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.
    Bianchi DW; Chudova D; Sehnert AJ; Bhatt S; Murray K; Prosen TL; Garber JE; Wilkins-Haug L; Vora NL; Warsof S; Goldberg J; Ziainia T; Halks-Miller M
    JAMA; 2015 Jul; 314(2):162-9. PubMed ID: 26168314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
    Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.
    Wang E; Batey A; Struble C; Musci T; Song K; Oliphant A
    Prenat Diagn; 2013 Jul; 33(7):662-6. PubMed ID: 23553731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma.
    Zhou Y; Zhu Z; Gao Y; Yuan Y; Guo Y; Zhou L; Liao K; Wang J; Du B; Hou Y; Chen Z; Chen F; Zhang H; Yu C; Zhao L; Lau TK; Jiang F; Wang W
    Reprod Sci; 2015 Nov; 22(11):1429-35. PubMed ID: 25963912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.